These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6362962)

  • 41. [Trial and evaluation of a new hepatoprotector, choleretic and antispasmodic preparation].
    Fernández Navarro MD; García Pérez M; Arias Vallejo E
    Rev Esp Enferm Apar Dig; 1972 Oct; 38(4):503-10. PubMed ID: 4629092
    [No Abstract]   [Full Text] [Related]  

  • 42. [Clinical evaluation of the chloasma treatment using a cholagogue-choleretic].
    D'Amico N
    Rev Bras Med; 1967 Dec; 24(12):1011-4. PubMed ID: 5619919
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical studies on the choleretic agent Febuprol (author's transl)].
    Scholing WE; Weinert W
    MMW Munch Med Wochenschr; 1978 Feb; 120(5):143-6. PubMed ID: 342924
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Drug-induced icterus caused by chloroquine].
    Klemm G
    Z Gesamte Inn Med; 1970 Apr; 25(8):374-6. PubMed ID: 5523265
    [No Abstract]   [Full Text] [Related]  

  • 45. [Therapeutic effect of a new molecule, epomediol, in intrahepatic cholestasis].
    Pasetti GC; De Simoni M; Giuberti T; Pedretti G; Pelosi G
    Clin Ter; 1982 May; 101(4):371-86. PubMed ID: 7105642
    [No Abstract]   [Full Text] [Related]  

  • 46. [Phalloidin antagonists 4th communication: Thioctic acid, SH-compounds, rifampicin, choleretics, dexamethasone, estradiol, unspecific inhibitors, and ineffective compounds (author's transl)].
    Frimmer M; Petzinger E; Homann J
    Arzneimittelforschung; 1975; 25(12):1881-4. PubMed ID: 766764
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of Cynarin on hyperlipidemia with special reference to type II (hypercholesterinemia)].
    Hammerl H; Kindler K; Kränzl C; Nebosis G; Pichler O; Studlar M
    Wien Med Wochenschr; 1973 Oct; 123(41):601-5. PubMed ID: 4583824
    [No Abstract]   [Full Text] [Related]  

  • 48. [Choleretic effect of Bulgarian rose oil].
    Tashev TA; Belousov AS; Gryneharov VP; Zhigalova MF
    Klin Med (Mosk); 1970 Aug; 48(8):57-61. PubMed ID: 5476044
    [No Abstract]   [Full Text] [Related]  

  • 49. Cytophotometric study of DNA in rabbit liver cells during experimental treatment of chronic hepatitis and liver cirrhosis.
    Leont'eva LI; Sherudilo AI; Iakobson GS
    Tsitologiia; 1971 May; 13(5):664-7. PubMed ID: 5561714
    [No Abstract]   [Full Text] [Related]  

  • 50. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
    Silveira MG; Lindor KD
    Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Roentgenologic evaluation of the choleretic effect of sorbite].
    Kitaev VV
    Ter Arkh; 1967 Aug; 39(8):40-3. PubMed ID: 5615300
    [No Abstract]   [Full Text] [Related]  

  • 52. Drug insight: Mechanisms and sites of action of ursodeoxycholic acid in cholestasis.
    Beuers U
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):318-28. PubMed ID: 16741551
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Treatment of cholestatic liver disease].
    Pleşa A
    Rev Med Chir Soc Med Nat Iasi; 2003; 107(4):733-6. PubMed ID: 14756010
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ursodeoxycholic acid in the treatment of cholestasis and hyperbilirubinemia in pediatric intensive care unit patients.
    George R; Stevens A; Berkenbosch JW; Turpin J; Tobias J
    South Med J; 2002 Nov; 95(11):1276-9. PubMed ID: 12539993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Considerations on the therapeutic effects of a new drug endowed with choleretic and hepato-protective activity].
    CONTRO L; CESANA A; MORI G
    Minerva Med; 1963 Mar; 54():743-7. PubMed ID: 14022732
    [No Abstract]   [Full Text] [Related]  

  • 56. [Insufficiency of bile formation and secretion in patients with viral hepatitis].
    Vasil'eva NA; Il'ina NI; Ishchuk IS; Kiĭko LG
    Klin Med (Mosk); 1988 May; 66(5):81-3. PubMed ID: 3419107
    [No Abstract]   [Full Text] [Related]  

  • 57. [The effect of cholerelics on bile flow in diseases of the liver and of the bile ducts (author's transl)].
    Bode JC; Strohmeyer G
    Leber Magen Darm; 1974 Apr; 4(2):65-71. PubMed ID: 4828906
    [No Abstract]   [Full Text] [Related]  

  • 58. [Pharmacological and clinical aspects of the use of a new choleretic, 1-morpholinoacetyl-3-phenyl-4-oxo-1,2,3,4-tetrahydroquinazoline hydrochloride].
    Grossi F; Spada S
    Clin Ter; 1969 Aug; 50(3):203-32. PubMed ID: 5387397
    [No Abstract]   [Full Text] [Related]  

  • 59. Choleretic effect of picroliv, the hepatoprotective principle of Picrorhiza kurroa.
    Shukla B; Visen PK; Patnaik GK; Dhawan BN
    Planta Med; 1991 Feb; 57(1):29-33. PubMed ID: 2062954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Diagnosis and treatment of intrahepatic cholestasis in chronic diseases of the liver].
    Golovanova EV; Petrakov AV
    Ter Arkh; 2011; 83(2):33-9. PubMed ID: 21516847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.